Streetbeat News

Products Services

SAM

The Boston Beer Company (NYSE:SAM) has entered the cannabis beverage market with its brand 'Teapot', a cannabis-infused iced tea. The brand has become popular in Canada, particularly in Quebec. The company has faced challenges in building brand awareness and expanding distribution, but sees potential for growth in the cannabis beverage market. The company is also considering the possibility of creating non-alcoholic cannabis-infused versions of their established beer brands if US regulations permit.

Portfolio Pulse from Nicolás Jose Rodriguez

November 01, 2023 | 8:22 pm

SLN

Silence Therapeutics announced positive results from the APOLLO phase 1 study of zerlasiran, showing significant reduction in lipoprotein(a) levels. The drug was well tolerated with no major safety concerns. HC Wainwright reiterated an $80 price target and Buy rating, predicting peak annual revenues of $2 billion for zerlasiran. SLN shares closed up 29.30% at $8.66 on Wednesday.

Portfolio Pulse from Vandana Singh

November 01, 2023 | 8:09 pm

MSFT

Microsoft Corporation (NASDAQ:MSFT) has announced the lineup of games coming to Xbox Game Pass in November 2023. The lineup includes games like Headbangers: Rhythm Royale, Jusant, Wartales, Thirsty Suitors, Football Manager 2024, and others. Eight games are set to leave Game Pass on November 15, including Football Manager 2023. This follows a recent announcement of an 'inevitable' price increase for the Xbox Game Pass.

Portfolio Pulse from Franca Quarneti

November 01, 2023 | 8:02 pm

LI

Li Auto Inc's shares are trading higher after the company announced a 302.1% YoY increase in October deliveries, reaching 40,422. The cumulative deliveries in 2023 reached 284,647. Li Auto has maintained its lead as the best-selling premium brand among SUVs in China. The company is also generating excitement for their upcoming Li MEGA 5C BEV model.

Portfolio Pulse from Henry Khederian

November 01, 2023 | 7:49 pm

KTRA

Kintara Therapeutics Inc (NASDAQ:KTRA) shares have dropped by 87% since Tuesday's open due to the company's decision to stop developing their drug VAL-083 for glioblastoma. The company is now focusing on REM-001, a localized tumor treatment, and exploring strategic options to enhance shareholder value. Preliminary results for VAL-083 were disappointing, but more data will be available in 2024. A study for REM-001 in cutaneous metastatic breast cancer is planned to start by the end of 2023, supported by a $2 million NIH grant.

Portfolio Pulse from Henry Khederian

November 01, 2023 | 7:11 pm

EYEN

William Blair initiated coverage on Eyenovia Inc (NASDAQ:EYEN) with an Outperform rating and an estimated fair value for shares of $3. The rating is based on a risk-adjusted net present value for Eyenovia's products and clinical-stage pipeline. The company recently received approval for MydCombi, validating the Optejet drug device. Eyenovia is also advancing treatments for progressive myopia in children presbyopia and has recently acquired the U.S. rights to APP13007, a potent topical steroid intended for post-ocular surgery use. William Blair anticipates Eyenovia's expansion of manufacturing operations in Redwood City, which is expected to pave the way for achieving profitability with the Optejet platform.

Portfolio Pulse from Vandana Singh

November 01, 2023 | 7:05 pm

CERS

Healthcare software and services company Bloodbuy has entered into an agreement with Cerus Corporation (NASDAQ:CERS) to offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex (IFC) via the Bloodbuy online marketplace. The IFC is a pathogen reduced blood component for fibrinogen supplementation with a 5-day post-thaw shelf life. This new blood product has the potential to make a huge impact on patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:53 pm

XPEV

XPeng Inc. has announced a significant increase in its vehicle delivery results for October 2023, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:52 pm

CNC

WMT

Walmart Health is expanding its healthcare services in Florida through collaborations with Ambetter from Sunshine Health and Orlando Health. The partnerships aim to provide Floridians with increased access to affordable healthcare options. Ambetter from Sunshine Health now includes Walmart Health Centers as a preferred provider in several Florida counties. This collaboration is an expansion of the existing relationship between Walmart Health and Ambetter Health, a leading healthcare program provided by Centene Corporation. Walmart Health has also expanded its footprint with 17 new Health Centers across Florida this year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:49 pm

ATVI

SONY

Sony Group Corp is releasing a PlayStation 5 Slim Disc Edition - Call of Duty: Modern Warfare III bundle, coinciding with the launch of Modern Warfare 3 on Nov. 10. The bundle is valued at $499, essentially offering the game for free. This is a significant first for the new PS5 model. There are also rumors of a PS5 Slim bundle with Spider-Man 2 for $560. The game is developed by Sledgehammer Games and published by Activision Blizzard Inc.

Portfolio Pulse from Franca Quarneti

November 01, 2023 | 6:47 pm